Europe Medical Isotope Market Size, Share & Trends Analysis Report By Type, By End User (Hospitals, Diagnostic Centers, and Research Institutes), By Application (Diagonostic, and Nuclear Therapy), By Country and Growth Forecast, 2023 - 2030
The Europe Medical Isotope Market would witness market growth of 8.3% CAGR during the forecast period (2023-2030).
The Germany market dominated the Europe Medical Isotope Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $575.6 million by 2030. The UK market is exhibiting a CAGR of 7.3% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.1% during (2023 - 2030)
Collaborative efforts between academia, industry, and healthcare institutions have fueled research and innovation in medical isotopes. Multidisciplinary research initiatives explore new isotopes, imaging techniques, and therapeutic approaches, driving advancements in nuclear medicine and molecular imaging. Regulatory approvals and market access pathways for medical isotopes have facilitated their adoption in clinical practice. Stringent regulatory oversight ensures the safety, efficacy, and quality of isotopic products, instilling confidence in healthcare providers and patients.
Additionally, medical isotopes have diverse applications across various fields of medicine, including diagnostic imaging, treatments, and biomedical research. Medical isotopes labeled with radioactive tracers are used in biomedical research to study physiological processes, molecular pathways, and disease mechanisms. Radiotracer studies help researchers investigate cellular metabolism, receptor binding, drug distribution, and disease progression.
The growth of the pharmaceutical industry in Belgium can drive competitiveness and innovation in the medical isotope market. According to the International Trade Administration (ITA), Belgium’s pharmaceutical industry spends $1.64 billion (€1.5 billion) on R&D annually, equivalent to 40 percent of all private investment made in Belgium. Hence, the expansion of the pharmaceutical industry and high expenditure in the region’s healthcare sector are driving the market’s growth.
Based on Type, the market is segmented into Radioisotopes, and Stable Isotopes. Based on End User, the market is segmented into Hospitals, Diagnostic Centers, and Research Institutes. Based on Application, the market is segmented into Diagnostic, and Nuclear Therapy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Mallinckrodt PLC
- Bayer AG
- GE HealthCare Technologies, Inc.
- Canadian Nuclear Laboratories (Atomic Energy Of Canada Limited)
- ITM Isotope Technologies Munich SE
- Siemens Healthineers AG
- Eczacibasi-Monrol
- NorthStar Medical Radioisotopes, LLC
- Nordion Inc. (Sotera Health LLC)
- Iba SA
By Type
- Radioisotopes
- Stable Isotopes
- Hospitals
- Diagnostic Centers
- Research Institutes
- Diagnostic
- Nuclear Therapy
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Medical Isotope Market, by Type
- 1.4.2 Europe Medical Isotope Market, by End User
- 1.4.3 Europe Medical Isotope Market, by Application
- 1.4.4 Europe Medical Isotope Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Opportunities
- 3.2.3 Market Restraints
- 3.2.4 Market Challenges
- 3.3 Porter’s Five Forces Analysis
- Chapter 4. Recent Strategies Deployed in Medical Isotopes Market
- Chapter 5. Europe Medical Isotope Market by Type
- 5.1 Europe Radioisotopes Market by Country
- 5.2 Europe Stable Isotopes Market by Country
- Chapter 6. Europe Medical Isotope Market by End User
- 6.1 Europe Hospitals Market by Country
- 6.2 Europe Diagnostic Centers Market by Country
- 6.3 Europe Research Institutes Market by Country
- Chapter 7. Europe Medical Isotope Market by Application
- 7.1 Europe Diagonostic Market by Country
- 7.2 Europe Nuclear Therapy Market by Country
- Chapter 8. Europe Medical Isotope Market by Country
- 8.1 Germany Medical Isotope Market
- 8.1.1 Germany Medical Isotope Market by Type
- 8.1.2 Germany Medical Isotope Market by End User
- 8.1.3 Germany Medical Isotope Market by Application
- 8.2 UK Medical Isotope Market
- 8.2.1 UK Medical Isotope Market by Type
- 8.2.2 UK Medical Isotope Market by End User
- 8.2.3 UK Medical Isotope Market by Application
- 8.3 France Medical Isotope Market
- 8.3.1 France Medical Isotope Market by Type
- 8.3.2 France Medical Isotope Market by End User
- 8.3.3 France Medical Isotope Market by Application
- 8.4 Russia Medical Isotope Market
- 8.4.1 Russia Medical Isotope Market by Type
- 8.4.2 Russia Medical Isotope Market by End User
- 8.4.3 Russia Medical Isotope Market by Application
- 8.5 Spain Medical Isotope Market
- 8.5.1 Spain Medical Isotope Market by Type
- 8.5.2 Spain Medical Isotope Market by End User
- 8.5.3 Spain Medical Isotope Market by Application
- 8.6 Italy Medical Isotope Market
- 8.6.1 Italy Medical Isotope Market by Type
- 8.6.2 Italy Medical Isotope Market by End User
- 8.6.3 Italy Medical Isotope Market by Application
- 8.7 Rest of Europe Medical Isotope Market
- 8.7.1 Rest of Europe Medical Isotope Market by Type
- 8.7.2 Rest of Europe Medical Isotope Market by End User
- 8.7.3 Rest of Europe Medical Isotope Market by Application
- Chapter 9. Company Profiles
- 9.1 Canadian Nuclear Laboratories (Atomic Energy of Canada Limited)
- 9.1.1 Company Overview
- 9.1.2 Recent strategies and developments:
- 9.1.2.1 Partnerships, Collaborations, and Agreements:
- 9.1.3 SWOT Analysis
- 9.2 ITM Isotope Technologies Munich SE
- 9.2.1 Company Overview
- 9.2.2 Recent strategies and developments:
- 9.2.2.1 Partnerships, Collaborations, and Agreements:
- 9.2.3 SWOT Analysis
- 9.3 ECZACIBAŞI-MONROL
- 9.3.1 Company Overview
- 9.3.2 Recent strategies and developments:
- 9.3.2.1 Partnerships, Collaborations, and Agreements:
- 9.3.3 SWOT Analysis
- 9.4 NorthStar Medical Radioisotopes, LLC
- 9.4.1 Company Overview
- 9.4.2 Recent strategies and developments:
- 9.4.2.1 Partnerships, Collaborations, and Agreements:
- 9.4.3 SWOT Analysis
- 9.5 Iba SA
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 SWOT Analysis
- 9.6 Mallinckrodt PLC
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 SWOT Analysis
- 9.7 GE HealthCare Technologies, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Partnerships, Collaborations, and Agreements:
- 9.7.6 SWOT Analysis
- 9.8 Nordion Inc. (Sotera Health LLC)
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.9 Bayer AG
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Partnerships, Collaborations, and Agreements:
- 9.9.6 SWOT Analysis
- 9.10. Siemens Healthineers AG (Siemens AG)
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook